You Position: Home > Paper

Advances of the drug resistance of the diffuse large B-cell lymphoma

( views:418, downloads:292 )
Author:
No author available
Journal Title:
JOURNAL OF LEUKEMIA & LYMPHOMA
Issue:
2
DOI:
10.3760/cma.j.issn.1009-9921.2011.02.027
Key Word:
淋巴瘤,大细胞,弥漫型;多药耐药相关蛋白质类;信号传导;Lymphoma,large-cell,diffuse;Multidrug resisbance-associated proteins;Signal transduction

Abstract: The chemoresistance of diffuse large B-cell lymphoma (DLBCL) is mainly due to drug resistance. Studies have shown that DLBCL resistance is related to the resistance gene and its resistancerelated protein, cytokines, adhesion molecules, which led to drug resistance through signal transduction in the hematopoietic microenvironment.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn